| NSCLC | Non-Small Cell Lung Cancer |
| IQR | Interquartile range |
| ICIs | Immune Checkpoint Inhibitors |
| pCR | Complete Pathological Response |
| MPR | Major Pathological Response |
| PFS | Progression-Free Survival |
| OS | Overall Survival |
| CT | Computed Tomography |
| 18 F FDG PET | 18 fluorodeoxyglucose positron emission tomography |
| MRI | Magnetic Resonance Imaging |
| EBUS | Endobronchial ultrasound |
| ESTS | European Society of Thoracic Surgery |
| PD-L1 | Programmed Cell Death Ligand 1 |
| TNM | Tumor Node Metastasis |
| MTB | Multidisciplinary Tumor Board |
| HER 2 SBRT |
Human epidermal growth factor receptor 2 Stereotactic body radiation therapy |
| VATS | Video-assisted thoracoscopic surgery |
| IASCL | International Association for the Study of Lung Cancer |
| BMI | Body Mass Index |
| CTCAE | Common Terminology Criteria for Adverse Events |
| CEAVNO | Comitato Etico Regione Toscana-Area Vasta Nord Ovest |
| SPSS | Statistical Package for the Social Sciences |
| SD | Standard Deviation |
| ECOG-PS COPD OSAS FEV1 FVC DLCO |
Eastern Cooperative Oncology Group Performance Status Chronic Obstructive Pulmonary Disease Obstructive Sleep Apnea Syndrome Forced Expiratory Volume in 1 s Forced Vital Capacity Diffusing capacity for carbon monoxide |
| OR | Odd Ratio |
| SE | Standard error |
| CI | Confidence Interval |
| RUL | Right Upper Lobe |
| RLL | Right Lower Lobe |
| RML | Right Middle Lobe |
| LUL | Left Upper Lobe |
| LLL | Left Lower Lobe |